https://www.selleckchem.com/pr....oducts/Gefitinib.htm
LINE-1 hypo-methylation mediated 83% of the inverse effect of BMI on breast cancer risk. This pilot study demonstrates that alterations in blood LINE-1 methylation mediate the inverse effect of BMI on breast cancer risk. This warrants large scale studies and stratification based on clinic-pathological types of breast cancer. This pilot study demonstrates that alterations in blood LINE-1 methylation mediate the inverse effect of BMI on breast cancer risk. This warrants large scale studies and stratification based on clinic-pathological
Like
Comment
Share
